CiplaResults

• Azeem Khan
• 14 May 2025

Cipla Q4 Profit Up 30%, But Caution Hits Stock—Should Investors Hold, Buy or Exit?

Despite reporting a robust 30% YoY rise in net profit for Q4FY25, pharma giant Cipla saw its shares